Nasr Deena M, Flemming Kelly D, Lanzino Giuseppe, Cloft Harry J, Kallmes David F, Murad Mohammad Hassan, Brinjikji Waleed
Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA.
Cerebrovasc Dis. 2018;45(1-2):68-77. doi: 10.1159/000486866. Epub 2018 Feb 13.
Vertebrobasilar non-saccular and dolichoectatic aneurysms (VBDA) are a rare type of aneurysm and are generally associated with poor prognosis. In order to better characterize the natural history of VBDAs, we performed a systematic review and meta-analysis of the literature to determine rates of mortality, growth, rupture, ischemia, and intraparenchymal hemorrhage.
We searched the literature for longitudinal natural history studies of VBDA patients reporting clinical and imaging outcomes. Studied outcomes included annualized rates of growth, rupture, ischemic stroke, intracerebral hemorrhage (ICH), and mortality. We also studied the association between aneurysm morphology (dolichoectatic versus fusiform) and natural history. Meta-analysis was performed using a random-effects model using summary statistics from included studies.
Fifteen studies with 827 patients and 5,093 patient-years were included. The overall annual mortality rate among patients with VBDAs was 13%/year (95% CI 8-19). Patients with fusiform aneurysms had a higher mortality rate than those with dolichoectatic aneurysms, but this did not reach statistical significance (12 vs. 8%, p = 0.11). The overall growth rate was 6%/year (95% CI 4-13). Patients with fusiform aneurysms had higher growth rates than those with dolichoectatic aneurysms (12 vs. 3%, p < 0.0001). The overall rupture rate was 3%/year (95% CI 1-5). Patients with fusiform aneurysms had higher rupture rates than those with dolichoectatic aneurysms (3 vs. 0%, p < 0.0001). The overall rate of ischemic stroke was 6%/year (95% CI 4-9). Patients with dolichoectatic aneurysms had higher ischemic stroke rates than those with fusiform aneurysms, but this did not reach statistical significance (8 vs. 4%, p = 0.13). The overall rate of ICH was 2%/year (95% CI 0-8) with no difference in rates between dolichoectatic and fusiform aneurysms (2 vs. 2%, p = 0.65).
In general, the natural history of -VBDAs is poor. However, dolichoectatic and fusiform -VBDAs appear to have distinct natural histories with substantially higher growth and rupture associated with fusiform aneurysms. These findings suggest that these aneurysms should be considered separate entities. Further studies on the natural history of vertebrobasilar dolichoectatic and fusiform aneurysms with more complete follow-up are needed to better understand the risk factors for progression of these aneurysms.
椎基底动脉非囊状及迂曲扩张性动脉瘤(VBDA)是一种罕见的动脉瘤类型,通常预后较差。为了更好地描述VBDA的自然病程,我们对文献进行了系统评价和荟萃分析,以确定死亡率、生长率、破裂率、缺血率和脑实质内出血率。
我们检索了关于VBDA患者纵向自然病程研究的文献,这些研究报告了临床和影像学结果。研究的结果包括年生长率、破裂率、缺血性卒中、脑出血(ICH)和死亡率。我们还研究了动脉瘤形态(迂曲扩张性与梭形)与自然病程之间的关联。使用随机效应模型对纳入研究的汇总统计数据进行荟萃分析。
纳入了15项研究,共827例患者,5093患者年。VBDA患者的总体年死亡率为13%/年(95%CI 8-19)。梭形动脉瘤患者的死亡率高于迂曲扩张性动脉瘤患者,但未达到统计学显著性(12%对8%,p = 0.11)。总体生长率为6%/年(95%CI 4-13)。梭形动脉瘤患者的生长率高于迂曲扩张性动脉瘤患者(12%对3%,p < 0.0001)。总体破裂率为3%/年(95%CI 1-5)。梭形动脉瘤患者的破裂率高于迂曲扩张性动脉瘤患者(3%对0%,p < 0.0001)。缺血性卒中的总体发生率为6%/年(95%CI 4-9)。迂曲扩张性动脉瘤患者的缺血性卒中发生率高于梭形动脉瘤患者,但未达到统计学显著性(8%对4%,p = 0.13)。ICH的总体发生率为2%/年(95%CI 0-8),迂曲扩张性和梭形动脉瘤之间的发生率无差异(2%对2%,p = 0.65)。
一般来说,VBDA的自然病程较差。然而,迂曲扩张性和梭形VBDA似乎有不同的自然病程,梭形动脉瘤的生长和破裂率明显更高。这些发现表明,这些动脉瘤应被视为不同的实体。需要对椎基底动脉迂曲扩张性和梭形动脉瘤的自然病程进行更全面随访的进一步研究,以更好地了解这些动脉瘤进展的危险因素。